An Insurance Industry Lesson for Pharma?
Article Excerpt
The industry has been consolidating. Governments and regulators are putting pressure on prices and requiring that margins be capped. Customers are alleging that products have been excessively marketed as "cure-alls" and that this has resulted in harm--and sometimes worse. The media have exposed a number of scandals in which companies have failed to appropriately disclose relevant information to purchasers and regulators. The industry scores poorly in surveys of trustworthiness and appears to get little credit for improving quality of life. And new channels of communication call into question the value of massed ranks of field-based sales people. Sound familiar? ...
Request the Full Article
Click here to request the full article. ZS articles and reports are provided at no cost. A business email address is required to process your request. After receipt of your request, a copy of the article will be emailed to your business email address.
About the Authors
Greg Ernest is a Principal with ZS Associates.
Tony Yeung is a Manager with ZS Associates.